Publications by authors named "Julie Butters"

Claim this Profile
S
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, John J P Kastelein, Christie M Ballantyne, Julie Butters

N Engl J Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
Peter J Psaltis, Mau T Nguyen, Kuljit Singh, Ajay Sinhal, Dennis T L Wong, Julie Butters

Cardiovasc Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.
Giuseppe Di Giovanni, Masashi Fujino, Yu Kataoka, Julie Butters, Thomas Hucko

Eur J Prev Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
Stephen J Nicholls, Sean Tan, Julie Butters, Adam J Nelson

Expert Opin Pharmacother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pop-up screening nested within routine community activities unmasks an addressed cardiovascular risk: A pilot study (Gippsland Healthy Heart Study).
Masashi Fujino, Julie Butters, Mark Boyes, Noel Duncan, Fleur Streets

Aust J Rural Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes.
Stephen J Nicholls, Yu Kataoka, Steven E Nissen, Francesco Prati, Stephan Windecker, Julie Butters

JACC Cardiovasc Imaging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Nicholas J Montarello, Kuljit Singh, Ajay Sinhal, Dennis T L Wong, Richard Alcock, Julie Butters

Cardiovasc Drugs Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
Stephen J Nicholls, Yu Kataoka, Steven E Nissen, Francesco Prati, Stephan Windecker, Julie Butters

JACC Cardiovasc Imaging· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region.
Hayato Tada, Khung Keong Yeo, Jian-Jun Li, Kathryn Tan, Junya Ako, Julie Butters

JACC Asia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.
Stephen J Nicholls, Steven E Nissen, Francesco Prati, Stephan Windecker, Yu Kataoka, Julie Butters

Cardiovasc Diagn Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tackling cardiometabolic risk in the Asia Pacific region.
Jian-Jun Li, Khung Keong Yeo, Kathyrn Tan, Junya Ako, Rungroj Krittayaphong, Julie Butters

Am J Prev Cardiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects.
Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, Khung Keong Yeo, Kathryn Tan, Julie Butters

Expert Opin Drug Metab Toxicol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism.
Varinderpal S Dhillon, Eric Yeoh, Carolyn Salisbury, Julie Butters, Addolorata Di Matteo

Environ Mol Mutagen· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
Stephen J Nicholls, Jordan Andrews, John J P Kastelein, Bela Merkely, Steven E Nissen, Julie Butters

JAMA Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs.
Julie Butters, Alex Brown, Liddy Griffith, Susan Kim, Stephen J Nicholls

Am J Cardiovasc Drugs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden.
Yu Kataoka, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Julie Butters

Cardiovasc Diagn Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study.
Jordan Andrews, Alex Janssan, Tracy Nguyen, Anthony D Pisaniello, Daniel J Scherer, Julie Butters

Cardiovasc Diagn Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of radiation-induced gastrointestinal morbidity: A prospective, longitudinal study following radiotherapy for carcinoma of the prostate.
Eric K Yeoh, Robin Krol, Varinderpal S Dhillon, Rochelle Botten, Addolorata Di Matteo, Julie Butters

Acta Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate.
Eric K Yeoh, Richard H Holloway, Robert J Fraser, Rochelle J Botten, Addolorata C Di Matteo, Julie Butters

Int J Radiat Oncol Biol Phys· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial.
Eric E Yeoh, Rochelle J Botten, Julie Butters, Addolorata C Di Matteo, Richard H Holloway

Int J Radiat Oncol Biol Phys· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.
Eric E Yeoh, Richard H Holloway, Robert J Fraser, Rochelle J Botten, Addolorata C Di Matteo, Julie Butters

Int J Radiat Oncol Biol Phys· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis